The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

Cigna’s Express Scripts could be nearing a settlement with the Federal Trade Commission in the agency’s lawsuit accusing the largest pharmacy benefit managers in the U.S. of driving up insulin prices.

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The Federal Trade Commission has paused its settlement review involving Express ...

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...

Based on ads released in advance of the Super Bowl, little has changed in the eyes of the pharma industry since the FDA began ...

The FTC paused its administrative case against major pharmacy benefit managers, including Cigna's Express Scripts and Evernorth Health, staying proceedings and discovery deadlines until July 1 to ...

The Federal Trade Commission and Cigna's Evernorth unit have officially reached a settlement that resolves allegations that the company's pharmacy benefit manager artificially drove up prices for ...

The potential deal comes about a year and a half after the FTC first brought the case against Express Scripts, CVS’ Caremark and UnitedHealth’s Optum Rx. If approved, the agreement would mark the ...

Earlier this week, the Federal Trade Commission paused its administrative case against major pharmacy benefit managers, including Cigna’s Express Scripts and Evernorth Health, staying proceedings and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The lawsuit alleges that insulin ...